Inhibition of ATP-induced cAMP formation by 5'-p- fluorosulfonylbenzoyladenosine in NG108-15 cells

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 2, 1998, Pages 153-159

  Ohkubo, Satoko ^a   Matsuoka, Isao ^a   Kimura, Junko ^a   Nakanishi, Hironori ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

5' p Fluorosulfonylbenzoyladenosine; ATP; CAMP; Methylene ATP; NG108 15 cells; Purinoceptor; ,

Indexed keywords

5' FLUOROSULFONYLBENZOYLADENOSINE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATE; CYCLIC AMP; LIGAND; PURINE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; RADIOIMMUNOASSAY; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0031663169     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005237     Document Type: Article

References (31)

1. Abbracchio MP, Burnstock G (1994) Purinoceptors: Are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-475
2. Anostario M Jr, Harrison ML, Geahlen RL (1990) Immunochemical detection of adenine nucleotide-binding protein with antibodies to 5′-p-fluorosulfonylbenzoyladenosine. Anal Biochem 190:60-65
3. cdc2 regulation. Mol Cell Biol 13:1673-1685
4. Barajas-López C, Muller MJ, Prieto-Gómez B, Espinosa-Luna R (1995) ATP inhibits the synaptic release of acetylcholine in submucosal neurons. J Pharmacol Exp Ther 274:1238-1245
5. Bennett JS, Colman RF, Colman RW (1978) Identification of adenine nucleotide binding proteins in human platelet membranes by affinity labeling with 5′-p-fluorosulfonylbenzoyl adenosine. J Biol Chem 253:7346-7354
6. 2Y-purinergic receptor that inhibits adenylyl cyclase. J Pharmacol Exp Ther 267:1140-1146
7. Côte S, Sande JV, Boeynaems J-M (1993) Enhancement of endothelial cAMP accumulation by adenine nucleotides: role of methylxanthine-sensitive sites. Am J Physiol 264:H1498-H1503
8. Figures WR, Scearce LM, DeFeo P, Stewart G, Zhou F, Chen J, Daniel J, Colman RF, Colman RW (1987) Direct evidence for the interaction of the nucleotide affinity analog 5′-p-fluorosulfonylbenzoyl adenosine with a platelet ADP receptor. Blood 70:796-803
9. Forsyth KM, Bjur RA, Westlall DP (1991) Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens. J Pharmacol Exp Ther 256:821-826
10. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156
11. Fu T, Chang W, Ishida N, Saida K, Mitsui Y, Okano Y, Nozawa Y (1989) Effects of vasoactive intestinal contractor (VIC) and endothelin on intracellular calcium levels in neuroblastoma NG108-15 cells. FEBS Lett 257:351-353
12. 1 adenosine receptor agonist. J Biol Chem 265:5206-5210
13. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450
14. 2-purinergic receptors: Subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 35:541-579
15. Kaiho H, Kimura J, Matsuoka I, Kumasaka T, Nakanishi H (1996) ATP-activated nonselective cation current in NG108-15 cells. J Neurochem 67:398-406
16. 1-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 346:187-196
17. Londos C, Wolff T (1977) Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci USA 74:5482-5486
18. Lustig KD, Shiau AK, Brake AJ, Julius D (1993) Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci USA 90:5113-5117
19. Matsuoka I, Zhou Q, Ishimoto H, Nakanishi H (1995) Extracellular ATP stimulates adenylyl cyclase and phospholipase C through distinct purinoceptors in NG108-15 cells. Mol Pharmacol 47:855-862
20. 2+ pathway in rabbit platelets. Br J Pharmacol 117:1095-1104
21. Olah ME, Stiles GL (1995) Adenosine receptor subtypes: Characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 35:581-606
22. Pal PK, Wechter WJ, Colman RF (1975) Affinity labeling of the inhibitory DPNH site of bovine liver glutamate dehydrogenase by 5′-fluorosulfonylbenzoyl adenosine. J Biol Chem 250:8140-8147
23. Palmer TM, Stiles GL (1995) Adenosine receptors. Neuropharmacology 34:683-694
24. 1 purinoceptors. Eur J Pharmacol 307:183-189
25. Poulos T, Price P (1974) The involvement of serine and carboxyl groups in the activity of bovine pancreatic deoxyribonuclease A. J Biol Chem 249:1453-1457
26. Rao AK, Kowalska MA (1987) ADP-induced platelet shape change and mobilization of cytoplasmic ionized calcium are mediated by distinct binding sites on platelets: 5′-p-fluorosulfonylbenzoyladenosine is a weak platelet agonist. Blood 70:751-756
27. Sato K, Okajima F, Kondo Y (1992) Extracellular ATP stimulates three different receptor-signal transduction systems in FRTL-5 thyroid cells: Activation of phospholipase C, and inhibition and activation of adenylate cyclase. Biochem J 283:281-287
28. Shinozuka K, Bjur RA, Westfall DP (1988) Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery. Naunyn-Schmiedeberg's Arch Pharmacol 338:221-227
29. 2 purinoceptor-mediated cyclic AMP accumulation in bovine vascular smooth muscle cells. Eur J Pharmacol 227:25-31
30. Yano K, Higashida H, Inoue R, Nozawa Y (1984) Bradykinin-induced rapid breakdown of phosphatidylinositol 4,5-bisphosphate in neuroblastoma x glioma hybrid NG108-15 cells. J Biol Chem 259:10201-10207
31. 3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436